BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:00 PM
 | 
Jul 22, 2009
 |  BC Extra  |  Clinical News

Nexavar meets breast cancer endpoint

Onyx Pharmaceuticals Inc. (NASDAQ:ONXX) gained $6.03 (21%) to $34.72 on Wednesday after it and partner Bayer AG (Xetra:BAY) said Nexavar sorafenib plus...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >